Agile Therapeutics (AGRX) Earnings Date, Estimates & Call Transcripts → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free AGRX Stock Alerts $0.34 -0.03 (-8.11%) (As of 03:58 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryLatest Earnings DateMar. 28ConfirmedActual EPS (Mar. 28) -$0.54 Missed By -$0.54 Listen to Call Get Agile Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AGRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAGRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AGRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressA lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one AGRX Earnings Date and InformationAgile Therapeutics last announced its earnings results on March 28th, 2024. The specialty pharmaceutical company reported ($0.54) EPS for the quarter. Agile Therapeutics has generated ($13.33) earnings per share over the last year (($13.33) diluted earnings per share). Agile Therapeutics has confirmed that its next quarterly earnings report will be published on Thursday, March 28th, 2024. Read More Agile Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/28/2024--($0.54)($0.54)--- 11/9/2023Q3 2023-($1.47)($1.47)($2.67)-$6.66 million8/9/2023Q2 2023($3.48)($3.10)+$0.38($4.05)$4.68 million$5.50 million5/11/2023Q1 2023-($7.76)($7.76)($9.61)-$3.81 million3/22/2023Q4 2022($10.50)($9.00)+$1.50($13.00)$3.17 million$4.00 million11/7/2022Q3 2022($0.30)($0.23)+$0.07$0.07$2.46 million$3.00 million Get the Latest News and Ratings for AGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Agile Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022-($2.71)($2.71)($2.71)$2.13 million$2.13 million 5/12/2022Q1 2022-($3.78)($3.78)($3.78)-$1.76 million3/30/2022Q4 2021($6.80)($8.00)($1.20)($0.20)$1.58 million$1.51 million 11/2/2021Q3 2021($7.60)($7.20)+$0.40($0.18)$1.49 million$1.29 million 7/25/2021Q2 2021($8.80)($8.00)+$0.80($0.20)$1.45 million$1.19 million 5/3/2021Q1 2021($8.40)($8.00)+$0.40($0.20)$0.65 million$0.12 million Agile Therapeutics Earnings - Frequently Asked Questions When is Agile Therapeutics's earnings date? Agile Therapeutics has confirmed that its next quarterly earnings data will be published on Thursday, March 28th, 2024. Learn more on AGRX's earnings history. How can I listen to Agile Therapeutics's earnings conference call? The conference call for Agile Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Agile Therapeutics generate each year? Agile Therapeutics (NASDAQ:AGRX) has a recorded annual revenue of $10.88 million. How much profit does Agile Therapeutics generate each year? Agile Therapeutics (NASDAQ:AGRX) has a recorded net income of -$25.41 million. AGRX has generated -$13.33 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Sunshine Biopharma Earnings 60 Degrees Pharmaceuticals Earnings Histogen Earnings Comera Life Sciences Earnings Dermata Therapeutics Earnings Qualigen Therapeutics Earnings 180 Life Sciences Earnings Cyclacel Pharmaceuticals Earnings Tenax Therapeutics Earnings Baudax Bio Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Lululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earnings This page (NASDAQ:AGRX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agile Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.